Snus Sales Triples in Switzerland, Raising Health Concerns

Market by 2FIRSTS.ai
May.06.2024
Snus Sales Triples in Switzerland, Raising Health Concerns
Swiss youth embrace nose tobacco, raising health concerns as sales triple, prompting debate on age restrictions.

According to NTB News on May 6th, snuff is becoming increasingly popular in Switzerland. More and more people in Switzerland, especially teenagers, are placing small packets containing nicotine under their upper lip, known as using snuff. This trend is causing concern among local dentists, who are seeing the consequences of this smoking behavior in their clinics. Snuff is made from dried and ground tobacco, seasoned with various salts, and added with different flavors. Additionally, there are so-called nicotine pouches, which are different from traditional snuff as they do not contain tobacco but still contain nicotine.

 

According to data from the Swiss Federal Customs Administration, sales of chewing tobacco, nasal snuff, and nicotine pouches in Switzerland reached 206 million Swiss francs last year, nearly triple the amount in 2019. The Federal Court's decision in 2019 was also a significant factor in the increased use of nasal snuff, ruling that the national ban on nasal snuff lacked legal basis.

 

Christoph Ramseier, a professor at the University of Bern's periodontology clinic, has noticed a rise in the use of nasal snuff, which can often lead to a condition known as gingival recession in the oral region. He told NZZ that in places where nasal snuff is used, the gums can become irritated, leading to gum recession and exposing the tooth roots. Even if individuals stop using nasal snuff, gum recession may continue to exist.

 

Lansel said, "The rate at which gum recession occurs is a personal factor that depends on the thickness of the gums. Once the tooth roots are exposed, individuals are more likely to be sensitive to cold and have an increased risk of developing lesions at the exposed area in the long term."

 

Lancel emphasized that young people receiving orthodontic treatment should be especially cautious. For them, their gums may become very thin due to the braces, and using snuff on top of that could lead to problems. Additionally, the use of snuff can also damage other oral mucosa.

 

"Nicotine pouches containing toxic and carcinogenic substances, while lower than chewing tobacco, can still cause thickening of the oral mucosa and formation of white wrinkles," Ransel said. These white wrinkles, known as leukoplakia, are early signs of cancer. However, research has not yet yielded significant results on the frequency of cancer among snuff users. Overall, the risk of cancer increases if smoking and alcohol consumption occur concurrently. "The good news is that if snuff use is stopped, leukoplakia will gradually fade," added Ransel.

 

Markus Meury, spokesperson for the Swiss Addiction Research Foundation (Sucht Schweiz), stated that the consumption of snuff among Swiss adolescents is also increasing. According to a study released last year, the proportion of 15-year-old boys who use snuff at least once a month has doubled from 2018 to 2022, reaching 13%, while the proportion of girls of the same age has increased from 1% to 6%.

 

The Zurich Addiction Research Foundation is now looking forward to the implementation of new tobacco product legislation and initiatives to ban tobacco advertising. This law will standardize the age for the sale of all nicotine products in Switzerland to 18 years old, and prohibit ads targeted towards children and teenagers. However, the proposal did not pass in the parliament session in February and will require renegotiation. It is unclear whether it will be able to take effect as planned in mid-2024.

 

However, even if the law is quickly enacted, Meri believes that strict enforcement is necessary. "As long as nicotine advertising is still targeted at young people, teenagers will want to buy these products and will find a way to do so," he says. He emphasizes that strict enforcement of the law is crucial, with the goal being to delay people from starting to use nicotine for as long as possible. This is because the earlier someone starts using nicotine, the more severe their dependence will be in the future.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

2Firsts Interview | Cigarette Sales Fall as Smokeless Alternatives Gain in U.S. Convenience Stores, NACS Says
2Firsts Interview | Cigarette Sales Fall as Smokeless Alternatives Gain in U.S. Convenience Stores, NACS Says
Ahead of the 2026 NACS Show, 2Firsts interviewed Chris Rapanick, NACS managing director of research, on changes reshaping the U.S. convenience-store tobacco and nicotine market. NACS data show cigarette sales declining while smokeless alternatives, including nicotine pouches, continue to grow. The interview also examines higher OTP margins, shifting backbar space, weaker store traffic, regulatory uncertainty and NACS’ outlook for 2027, offering a retailer-side view of one of the world’s largest nicotine markets.
Interview
Oct.03
Kumulus Vape2026 H1 Revenue Falls 8.3% but Profit Rises 24% as B2B Weakens and Consumer Channels Grow
Kumulus Vape2026 H1 Revenue Falls 8.3% but Profit Rises 24% as B2B Weakens and Consumer Channels Grow
French vaping company Kumulus Vape reported first-half 2026 revenue of €25.5 million, down 8.3% year over year, as its core B2B distribution business fell 11% to €21.6 million. B2C and store-network revenue rose 5.6% and 17.8%, respectively. Commercial margin increased to 26.3% from 21.7%, while net profit rose 24.1% to €0.8 million. The company attributed the profitability improvement to catalog optimization, logistics restructuring and the ramp-up of Labster, its in-house production unit for proprietary brands.
Market
Sep.17 by 2Firsts Perspectives
STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
U.S. Customs and Border Protection ruled that STIIIZY had not shown that the redesigned cannabis-vape products covered by its latest request fall outside an ITC limited exclusion order tied to PAX Labs patents. CBP accepted some of STIIIZY’s claim-construction and non-infringement arguments, but the company did not address two additional claims in the same patent. Earlier STIIIZY redesigned cartridges and certain associated components imported with them had received separate CBP clearance.
Sep.16
AIR Q3 Sales Rise 11%, but New Products Generate Just $2.1 Million in Nine Months as U.S. Vape Push Awaits FDA Review
AIR Q3 Sales Rise 11%, but New Products Generate Just $2.1 Million in Nine Months as U.S. Vape Push Awaits FDA Review
AIR Global PLC (NASDAQ: AIIR), a producer of flavored shisha tobacco and next-generation nicotine products, reported an 11.1% increase in third-quarter 2026 revenue to $99.8 million and a 7.7% rise in adjusted EBITDA to $30.9 million. Revenue for the first nine months increased 6.0% to $306.7 million, but the company posted a $74.2 million net loss, affected by listing-related expenses and other costs. Its New Growth Categories (NGC) business generated $2.1 million in nine-month revenue and an adjusted EBITDA loss of $10.8 million. AIR maintained its 2026 revenue growth guidance of 4%–6%, while lowering its capital expenditure outlook and raising its year-end leverage forecast from approximately 2.1 times to 2.5 times. The company has submitted a U.S. PMTA for its Crown Switch pod vape, with future contributions from new products dependent on regulatory progress and commercialization.
Capital Markets
Nov.13
Japanese Addiction Psychiatrist Says Complete Abstinence Is Not Always the Goal of Harm Reduction | 2Firsts Interview
Japanese Addiction Psychiatrist Says Complete Abstinence Is Not Always the Goal of Harm Reduction | 2Firsts Interview
Complete abstinence is not always the goal of addiction treatment under a harm-reduction approach, Japanese psychiatrist Tomohiro Shirasaka told 2Firsts in Manila. In the interview, he discussed patients' quality of life, Japan's shift towards heated tobacco products, and the challenges of quitting smoking for people with mental illness. Drawing on addiction treatment work in the Philippines, he advocated support rather than punishment and questioned whether fear-based health warnings effectively address the reasons people continue smoking.
Nov.10
EU Tobacco Tax Reform Stalls as Malta Withholds Support Despite Backing From 26 States
EU Tobacco Tax Reform Stalls as Malta Withholds Support Despite Backing From 26 States
EU finance ministers failed to reach agreement on tobacco excise reform at the November 9, 2026 Economic and Financial Affairs Council (ECOFIN) meeting in Brussels. The Irish Council presidency's compromise secured support from 26 of the EU's 27 member states, but Malta withheld consent, preventing the Council from reaching a general approach requiring unanimity. The reform would raise minimum taxes on conventional tobacco and bring e-cigarette liquids, heated tobacco and nicotine pouches into a common EU minimum excise framework. Finland and Estonia accepted further concessions during the meeting, while the presidency proposed separating the inclusion of nicotine pouches in the framework from setting their precise minimum tax rates. Another compromise would allow ten qualifying member states until 2036 to meet certain tobacco excise requirements. Ireland intends to continue negotiations in December.
Regulations
Nov.11